IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Palo Alto Investors LP

Q3 2024 Holdings

Filed 2024-11-14 | 45 holdings | $769.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Insmed Inc(INSM)COM PAR $.01457669307$141.7M1,940,99318.4%
Amicus Therapeutics Inc(FOLD)COM03152W109$87.0M8,145,31111.3%
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$76.6M1,090,05610.0%
United Therapeutics Corp(UTHR)COM91307C102$65.7M183,2468.5%
Biogen Inc(BIIB)COM09062X103$44.4M228,9165.8%
Staar Surgical Co(STAA)COM PAR $0.01852312305$40.6M1,091,6085.3%
Acadia Pharmaceuticals Inc(ACAD)COM004225108$38.8M2,523,9565.0%
Alnylam Pharmaceuticals Inc(ALNY)COM02043Q107$38.7M140,6815.0%
Prothena Corp PLC(PRTA)SHSG72800108$29.1M1,737,9643.8%
Iovance Biotherapeutics Inc(IOVA)COM462260100$28.6M3,041,6853.7%
Anaptysbio Inc(ANAB)COM032724106$28.3M843,9713.7%
Sarepta Therapeutics Inc(SRPT)COM803607100$26.3M210,2583.4%
Alkermes PLC(ALKS)SHSG01767105$10.8M384,6561.4%
PTC Therapeutics Inc(PTCT)COM69366J200$9.8M264,4691.3%
Align Technology Inc(ALGN)COM016255101$9.6M37,7721.2%
Ehealth Inc(EHTH)COM28238P109$9.6M2,347,5191.2%
Novocure LTD(NVCR)ORD SHSG6674U108$9.3M593,5401.2%
Acelyrin IncCOM00445A100$8.8M1,792,8951.1%
Revance Therapeutics Inc(RVNCEUR)COM761330109$8.4M1,611,7871.1%
Syndax Pharmaceuticals Inc(SNDX)COM87164F105$7.8M405,1931.0%
Sage Therapeutics Inc(SG7)COM78667J108$7.3M1,010,8330.9%
Gossamer BIO Inc(GOSS)COM38341P102$6.2M6,277,0930.8%
Karyopharm Therapeutics Inc(KPTIEUR)COM48576U106$4.2M5,102,1930.6%
Nevro Corp(NVROEUR)COM64157F103$4.2M750,3710.5%
Biontech SE(BNTX)SPONSORED ADS09075V102$3.0M25,2060.4%
Verve Therapeutics IncCOM92539P101$2.8M575,8170.4%
Edwards Lifesciences Corp(EW)COM28176E108$2.6M39,4730.3%
Mirum Pharmaceuticals Inc(MIRM)COM604749101$2.5M64,7000.3%
Relmada Therapeutics Inc(RLMD)COM75955J402$2.4M732,4000.3%
Nuvation BIO Inc(NUVB)COM CL A67080N101$1.8M772,6520.2%
Taysha Gene Therapies Inc(TSHA)COM SHS877619106$1.6M811,2680.2%
Travere Therapeutics Inc(TVTX)COM89422G107$1.5M110,7190.2%
Stoke Therapeutics Inc(STOK)COM86150R107$1.5M125,8610.2%
Bicycle Therapeutics PLC(BCYC)SPONSORED ADS088786108$1.3M59,5820.2%
Humana Inc(HUM)COM444859102$1.3M3,9850.2%
Aldeyra Therapeutics Inc(ALDX)COM01438T106$1.2M225,4650.2%
Vyne Therapeutics Inc Pipe(VYNE)COM92941V308$837.4K445,4340.1%
Elevation Oncology IncCOM28623U101$778.7K1,298,0970.1%
Instil BIO Inc(TIL)COM NEW45783C200$751.6K11,1650.1%
Aclaris Therapeutics Inc(ACRS)COM00461U105$655.3K569,8320.1%
Pyxis Oncology Inc(PYXS)COMMON STOCK747324101$623.9K170,0000.1%
Generation BIO Co(GBIOGBX)COM37148K100$371.7K150,4750.0%
Bluebird BIO IncCOM09609G100$313.9K604,2600.0%
Urogen Pharma LTD(URGN)COMM96088105$311.2K24,5000.0%
Abeona Therapeutics Inc(ABEO)COM NEW00289Y206$81.3K12,8650.0%